Empresa Cerevel Therapeutics Holdings, Inc.
Acciones
CERE
US15678U1280
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
42,47 USD | +0,95 % | +0,62 % | +0,17 % |
Resumen de negocios
Número de empleados: 334
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ronald Renaud
CEO | Chief Executive Officer | 55 | 12/06/23 |
Director of Finance/CFO | 43 | 15/05/23 | |
N. Coles
CHM | Chairman | 63 | 01/12/18 |
Raymond Sanchez
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/01/19 |
John Renger
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/05/19 |
53 | - | ||
Matthew Calistri
IRC | Investor Relations Contact | - | - |
Scott Akamine
LAW | General Counsel | 40 | 24/05/21 |
Mark Bodenrader
AUD | Comptroller/Controller/Auditor | 51 | 01/09/19 |
Paul Burgess
PRN | Corporate Officer/Principal | 50 | 20/06/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 63 | 01/06/19 | |
Ruth McKernan
BRD | Director/Board Member | 66 | 04/12/20 |
Deval Patrick
BRD | Director/Board Member | 67 | 20/01/21 |
Marijn Dekkers
BRD | Director/Board Member | 65 | 01/09/18 |
Norbert Riedel
BRD | Director/Board Member | 66 | 01/12/18 |
N. Coles
CHM | Chairman | 63 | 01/12/18 |
Ronald Renaud
CEO | Chief Executive Officer | 55 | 12/06/23 |
Director/Board Member | 51 | 01/09/18 | |
Suneet Varma
BRD | Director/Board Member | 55 | 14/06/22 |
Deborah Baron
BRD | Director/Board Member | 55 | 20/01/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 181 576 482 | 76 702 134 ( 42,24 %) | 0 | 42,24 % |
Información de la empresa
Cerevel Therapeutics Holdings, Inc.
222 Jacobs Street Suite 200
02141, Cambridge
+844 304 2048
http://www.cerevel.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+0,17 % | 7711,55 M | |
-2,31 % | 103 mil M | |
+0,56 % | 95,28 mil M | |
+1,69 % | 22,15 mil M | |
-17,37 % | 21,02 mil M | |
-9,30 % | 18,15 mil M | |
-41,01 % | 16,73 mil M | |
-14,85 % | 16,05 mil M | |
+3,21 % | 13,68 mil M | |
+33,54 % | 12,17 mil M |
- Bolsa de valores
- Acciones
- Acción CERE
- Empresa Cerevel Therapeutics Holdings, Inc.